home / stock / lnth / lnth news

LNTH News and Press, Lantheus Holdings Inc. From 03/05/24

Stock Information
Company Name: Lantheus Holdings Inc.
Stock Symbol: LNTH
Market: NASDAQ
Website: lantheus.com
Menu
LNTH LNTH Quote LNTH Short LNTH News LNTH Articles LNTH Message Board
Get LNTH Alerts

News, Short Squeeze, Breakout and More Instantly...
LNTH - Lantheus to Present at the Leerink Partners Global Biopharma Conference 2024

BEDFORD, Mass., March 05, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced Paul Blanchf...
LNTH - Lantheus Announces the FDA Approval of DEFINITY® (Perflutren Lipid Microsphere) for Pediatric Patients

BEDFORD, Mass., March 04, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow ® disease to deliver better patient outcomes, today announced t...

LNTH - Lantheus Announces Promotion of Amanda Morgan to Chief Commercial Officer

BEDFORD, Mass., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced the promotion...

LNTH - Lantheus to Present at the TD Cowen 44th Annual Health Care Conference

BEDFORD, Mass., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced Paul Blanchfi...
LNTH - Radiopharmaceutical market expected to reach ~$14B by 2032

2024-02-25 12:00:00 ET More on AstraZeneca, Bristol-Myers, etc. Eli Lilly: Will It Be The First Ever Trillion-Dollar Drug Company? Eli Lilly: Yes, It Is Too Late To Join The Party Eli Lilly: Very Strong Fundamentals, But Market Is Euphoric Phase 3 data for As...

LNTH - Market Outperform Recommendation Issued On LNTH By JMP Securities

2024-02-23 13:30:04 ET JMP Securities analyst issues MARKET OUTPERFORM recommendation for LNTH on February 23, 2024 01:00PM ET. The previous analyst recommendation was Market Outperform. LNTH was trading at $66.21 at issue of the analyst recommendation. The overall analy...

LNTH - Lantheus Holdings, Inc. (LNTH) Q4 2023 Earnings Call Transcript

2024-02-22 15:24:03 ET Lantheus Holdings, Inc. (LNTH) Q4 2023 Earnings Conference Call February 22, 2024 08:00 AM ET Company Participants Mark Kinarney - VP, IR Mary Anne Heino - CEO Brian Markison - Chairman Paul Blanchfield - President Bob Marshall - CF...
LNTH - Lantheus Q4 2023 Earnings Preview

2024-02-21 11:35:39 ET More on Lantheus Lantheus Stock: Looking To Add After SPLASH's Belly-Flop Lantheus: SPLASHdown, Navigating Waves In MCRPC Treatment Perspective gains as B. Riley sees over 100% upside on radiopharma prospects Lantheus appoints CEO ...

LNTH - Lantheus Announces Collaboration to Provide Novel Tau Imaging Agent for Large Consortium Clinical Trial Sponsored by the National Institute on Aging

Lantheus to supply MK-6240, an investigational F18-labeled PET imaging agent that targets tau tangles BEDFORD, Mass., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling ...

LNTH - Lantheus to Host Fourth Quarter and Full Year 2023 Earnings Conference Call and Webcast on February 22, 2024, at 8:00 a.m. Eastern Time

BEDFORD, Mass., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Thursday, February 22, 2024, to discuss its financial and operating results for the fou...
Previous 10 Next 10